Skip to main content

Lin Peter Kuan-How's Form 4/A amendment

Amended

Apollomics Inc. (APLM) · filed Sep 24, 2026

Accession no.
0001193125-26-401336
Filed
Sep 24, 2026, 7:49 PM ET
Trade date
Sep 14-15, 2026
Filing delay
10 days
Rule 10b5-1 plan
Not checked
Original filed
Sep 17, 2026

This filing lists 2 non-derivative transactions and 2 derivative transactions. It was filed 10 days after the trade.

This amendment replaces 0001193125-26-394809 (filed Sep 17, 2026).

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Lin Peter Kuan-HowCIK 0002112997Officer (Chief Financial Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 15, 2026CLASS A ORDINARY SHARESMOption exerciseAcquired+10,000$0.00$058,979Direct
Sep 15, 2026CLASS A ORDINARY SHARESFTax withholdingDisposed−3,416$24.02−$82,052.3255,563Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Sep 14, 2026CLASS A ORDINARY SHARESAGrant or awardAcquired+6,000$0.00$06,000Direct
Sep 15, 2026CLASS A ORDINARY SHARESMOption exerciseDisposed−10,000$0.00$010,000Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

The stock option was granted under the Apollomics Inc. 2023 Incentive Award Plan on September 14, 2026. The option vests and becomes exercisable over a one-year period: fifty percent (50%) of the shares subject to the option vest on March 14, 2027 (six months from the grant date), and the remaining fifty percent (50%) vest on September 14, 2027 (twelve months from the grant date), subject to the reporting person's continued service to the Issuer through each applicable vesting date.

F2

Each restricted stock unit represents a contingent right to receive one Class A Ordinary Share

F3

RSUs were granted and previously reported on a Form 3 filed March 18, 2026 and a Form 3/A filed April 14, 2026. Of the initial RSU grant, 10,000 shares vested on each of February 9, 2026, March 15, 2026, June 15, 2026 and September 15, 2026. This transaction represents the vesting of 10,000 RSUs on September 15, 2026.

Remarks

This Form 4 is being amended to correct the expiration date of the stock option.

Read the full filing on SEC EDGAR (opens in a new tab)